C86.01: Extranodal NK/T-cell lymphoma, nasal type, in remission
C86.01 is a billable, specific ICD-10-CM code for extranodal nk/t-cell lymphoma, nasal type, in remission. It is valid for submission on a claim.
Check C86.01 with the rest of the claim: free scrubberExcludes1 inherited from the categories above C86.01
A category’s note binds every code beneath it.
Other codes that can never be billed with C86.01
Their own Excludes1 notes name this code, so the conflict is not listed above.
- C85Other specified and unspecified types of non-Hodgkin lymphoma
Risk adjustment
C86.01 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C86.01 is named in 25 Medicare coverage policies: 25 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A55717Billing and Coding: Lab: Flow Cytometry
Code history
- addedFY2024-FY2027
Extranodal NK/T-cell lymphoma, nasal type, in remission